NOVT Q1 Deep Dive: AI-Driven Demand and New Products Propel Growth Amid Margin Pressures
Novanta (NASDAQ:NOVT) reported stronger-than-expected first-quarter 2026 results, with management citing broad-based bookings growth, accelerating demand in automation and medical markets, and rising exposure...
Novanta (NASDAQ:NOVT) Surprises With Q1 CY2026 Sales
First Quarter 2026 GAAP Revenue increased 10% to $258 million First Quarter 2026 GAAP Net Income was $21 million, and Adjusted EBITDA increased 14% to...
Barchart Research What to Expect from NOVT Earnings NOVT Generated May 8, 2026 Current Price $138.31 EPS Estimate $$0.77 Consensus Rating Strong Buy Average Move 4.99% Novanta's Medical Equipment Exposure...
Novanta Earnings: What To Look For From NOVT
Barchart Research What to Expect from NOVT Earnings NOVT Generated May 8, 2026 Current Price $138.31 EPS Estimate $$0.77 Consensus Rating Strong Buy Average Move 4.99% Novanta's Medical Equipment Exposure...
Barchart Research What to Expect from NOVT Earnings NOVT Generated May 8, 2026 Current Price $138.31 EPS Estimate $$0.77 Consensus Rating Strong Buy Average Move 4.99% Novanta's Medical Equipment Exposure...
3 Profitable Stocks That Concern Us